J. Bonhoeffer

发表

Evaluation of a multinational, multilingual vaccine debate on Twitter.

M. Sturkenboom, E. V. van Mulligen, H. Larson, 2016, Vaccine.

Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?

J. Lei, M. Schuemie, P. Coloma, 2014, Journal of internal medicine.

Report on terminology mapping and AEFI/ADE definitions

K. Verhamme, M. Sturkenboom, J. Bonhoeffer, 2011 .

Safety of pandemic H1N1 vaccines in children and adolescents.

J. Dieleman, M. Sturkenboom, J. Bonhoeffer, 2011, Vaccine.

Otitis media and its consequences: beyond the earache.

E. Sanders, E. Simões, A. Hoberman, 2010, The Lancet. Infectious diseases.

International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.

Tao Zhang, Jan Bonhoeffer, Harald Heijbel, 2013, Vaccine.

The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI).

Robert T. Chen, Philippe Duclos, Tom Jefferson, 2002, Vaccine.

Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe

Jan Bonhoeffer, Miriam Sturkenboom, Silvana Romio, 2011, BMJ : British Medical Journal.

International Collaborative Case Series Safety Monitoring for Pandemic 2009 H1N1 Vaccines: Estimation of the Risk of Guillain-Barre Syndrome

M. Sturkenboom, S. Black, J. Bonhoeffer, 2012 .

The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). Guide on Methodological Standards in Pharmacoepidemiology (Revision 1, 2012, Revision 2, 2013, Revision 3, 2014)).

A. Fourrier-Réglat, J. Hallas, S. Evans, 2012 .

A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark.

K. Johansen, N. Andrews, J. Bonhoeffer, 2012, Vaccine.

Adherence to the paediatric immunisation schedule in England

S. de Lusignan, N. Künzli, J. Bauwens, 2021, Vaccine: X.

Co-administration of routine paediatric vaccines in England often deviates from the immunisation schedule

S. de Lusignan, N. Künzli, J. Bauwens, 2021, Vaccine: X.

Factors affecting the causality assessment of adverse events following immunisation in paediatric clinical trials: An online survey.

M. Voysey, J. Bonhoeffer, M. Snape, 2015, Vaccine.

Kawasaki disease and immunisation: Standardised case definition & guidelines for data collection, analysis.

J. Newburger, N. Dahdah, S. D. de Ferranti, 2016, Vaccine.

Vasculitic peripheral neuropathy: Case definition and guidelines for collection, analysis, and presentation of immunisation safety data.

S. Hsieh, J. Bonhoeffer, S. Živković, 2017, Vaccine.

Acute aseptic arthritis: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data.

F. Pourmalek, J. Bauwens, J. Oleske, 2019, Vaccine.

Acute wheeze in the pediatric population: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.

J. Bauwens, K. Edwards, J. Crane, 2017, Vaccine.

Systemic Lupus Erythematosus: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.

G. Alarcón, J. Bonhoeffer, A. Hersh, 2016, Vaccine.

Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data.

R. Steele, J. Sejvar, J. Galama, 2007, Vaccine.

Vasculitis as an adverse event following immunization - Systematic literature review.

G. Alarcón, S. Ozen, G. Girolomoni, 2016, Vaccine.

Update on new vaccines and immunisation strategies

J. Bonhoeffer, P. Heath, 2006 .

Immunization in pregnancy clinical research in low- and middle-income countries – Study design, regulatory and safety considerations

S. Kochhar, S. Hirschfeld, J. Bauwens, 2017, Vaccine.

Immunization of pregnant women is a promising public health strategy to reduce morbidity and mortality among both the mothers and their infants. Establishing safety and efficacy of vaccines generally uses a hybrid design between a conventional interventional study

S. Kochhar, S. Hirschfeld, J. Bauwens, 2017 .

Kawasaki disease and immunisation: A systematic review.

J. Newburger, N. Dahdah, S. D. de Ferranti, 2017, Vaccine.

Human metapneumovirus infections—biannual epidemics and clinical findings in children in the region of Basel, Switzerland

U. Schaad, U. Heininger, J. Bonhoeffer, 2009, European Journal of Pediatrics.

Risk of intussusception after monovalent rotavirus vaccine (Rotavac) in Indian infants: A self-controlled case series analysis

A. Dubey, J. Tate, U. Parashar, 2020, Vaccine.

Intussusception in children aged under two years in India: Retrospective surveillance at nineteen tertiary care hospitals

A. Dubey, Atul Gupta, J. Mathai, 2020, Vaccine.

Three-Year Surveillance of Intussusception in Children in Switzerland

U. Schaad, U. Heininger, J. Bonhoeffer, 2007, Pediatrics.

Wheeze as an adverse event in pediatric vaccine and drug randomized controlled trials: A systematic review.

J. Ortiz, G. John-Stewart, D. Marangu, 2015, Vaccine.

Procalcitonin Guidance to Reduce Antibiotic Treatment of Lower Respiratory Tract Infection in Children and Adolescents (ProPAED): A Randomized Controlled Trial

P. Schuetz, B. Mueller, U. Schaad, 2013, PloS one.

The development of standardized case definitions and guidelines for adverse events following immunization.

Robert T. Chen, M. Braun, T. Jefferson, 2007, Vaccine.

Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

T. Tapiainen, J. Bonhoeffer, F. Varricchio, 2007, Vaccine.

A systematic review of adverse events following immunization during pregnancy and the newborn period

S. Omer, J. Ortiz, J. Bonhoeffer, 2015, Vaccine.

The Role of Bordetella Infections in Patients with Acute Exacerbation of Chronic Bronchitis

U. Heininger, J. Bonhoeffer, M. Riffelmann, 2005, Infection.

Global alignment of immunization safety assessment in pregnancy - The GAIA project.

S. Kochhar, M. Sturkenboom, S. Hirschfeld, 2016, Vaccine.

Persistent crying in infants and children as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.

W. Walop, S. Halperin, J. Bonhoeffer, 2004, Vaccine.

Seroprevalence and immunization history of selected vaccine preventable diseases in medical students.

U. Schaad, U. Heininger, J. Bonhoeffer, 2005, Vaccine.

CHILDREN'S HOSPITALS

A. Gervaix, D. Nadal, H. Gnehm, 2014 .

Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents

D. Nadal, U. Schaad, U. Heininger, 2005, European Journal of Pediatrics.

Pediatric Drug Safety Signal Detection: A New Drug–Event Reference Set for Performance Testing of Data-Mining Methods and Systems

K. Verhamme, M. Sturkenboom, M. Catapano, 2015, Drug Safety.

Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines – Multi-country assessment

B. Carleton, M. Sturkenboom, S. Overeem, 2018, Vaccine.

Pandemic influenza vaccine & narcolepsy: simulations on the potential impact of bias

M. Sturkenboom, S. Overeem, S. Black, 2016, Expert review of vaccines.

Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy☆

S. Kochhar, S. Black, M. Steinhoff, 2016, Vaccine.

Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases.

S. Kochhar, S. Ozen, G. Girolomoni, 2016, Vaccine.

Safety of routine childhood vaccine coadministration versus separate vaccination

S. de Lusignan, N. Künzli, J. Bauwens, 2022, BMJ Global Health.

Obstetrical and neonatal case definitions for immunization safety data

Robert T. Chen, J. Bauwens, J. Bonhoeffer, 2016, Vaccine.

Unexplained sudden death, including sudden infant death syndrome (SIDS), in the first and second years of life: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

T. Tapiainen, U. Heininger, J. Bonhoeffer, 2007, Vaccine.

Reporting of vaccine safety data in publications: systematic review

U. Heininger, J. Bonhoeffer, B. Zumbrunn, 2005, Pharmacoepidemiology and drug safety.

Safety of Co-Administration Versus Separate Administration of the Same Vaccines in Children: A Systematic Literature Review

N. Künzli, J. Bauwens, J. Bonhoeffer, 2019, Vaccines.

heeze as an adverse event in pediatric vaccine and drug andomized controlled trials : A systematic review

J. Bonhoeffer, iana Marangua, S. Kovacsb, 2015 .

Prospective surveillance for intussusception in Indian children aged under two years at nineteen tertiary care hospitals

A. Dubey, Atul Gupta, H. S, 2020, BMC Pediatrics.

Anaphylaxis as an adverse event following immunisation

M. Erlewyn-Lajeunesse, J. Bonhoeffer, P. Heath, 2006, Journal of Clinical Pathology.

Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage

S. Kochhar, J. Bauwens, P. Pitisuttithum, 2018, Journal of clinical pharmacology.

Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: case definition and guidelines for data collection, analysis, and presentation.

S. Halperin, U. Heininger, J. Bonhoeffer, 2007, Vaccine.

Evaluation of the Brighton Collaboration case definition of acute intussusception during active surveillance.

T. Tapiainen, U. Heininger, J. Bonhoeffer, 2006, Vaccine.

Prospective study on central venous line associated bloodstream infections

T. Erb, U. Heininger, J. Bonhoeffer, 2011, Archives of Disease in Childhood.

Adverse events following immunization: perception and evidence

U. Heininger, J. Bonhoeffer, 2007, Current opinion in infectious diseases.

PROTECTION AGAINST VACCINE-PREVENTABLE DISEASES IN MEDICAL STUDENTS

U. Schaad, U. Heininger, J. Bonhoeffer, 2003, The Pediatric infectious disease journal.

Paediatric and neonatal infections 237 Adverse events following immunization: perception and evidence.

R. Booy, S. Lambert, U. Heininger, 2007 .

Impact of Sepsis on Neurodevelopmental Outcome in a Swiss National Cohort of Extremely Premature Infants

P. Latzin, H. Bucher, G. Natalucci, 2011, Pediatrics.

The Brighton Collaboration: Creating a Global Standard for Case Definitions (and Guidelines) for Adverse Events Following Immunization

Robert T. Chen, Philippe Duclos, Katrin S. Kohl, 2005 .

Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.

Jan Bonhoeffer, Ulrich Heininger, M. Mäkelä, 2007, Vaccine.

Reliability of varicella history in children and adolescents.

U. Schaad, U. Heininger, J. Bonhoeffer, 2005, Swiss medical weekly.

The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns.

Sebastiaan Overeem, Poul Jennum, Gert Jan Lammers, 2013, Vaccine.

Standardized case definitions of adverse events following immunization (AEFI).

Robert T. Chen, T. Jefferson, U. Heininger, 2004, Vaccine.

Safety assessment of immunization in pregnancy☆

S. Kochhar, J. Bauwens, J. Bonhoeffer, 2017, Vaccine.

Arthritis and arthralgia as an adverse event following immunization: A systematic literature review.

F. Pourmalek, J. Bonhoeffer, A. Woerner, 2019, Vaccine.

Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation.

F. Poli, G. Plazzi, M. Sturkenboom, 2013, Vaccine.

IgA vasculitis (Henoch-Schönlein): Case definition andguidelines for data collection, analysis, and presentation of immunisation safety data.

S. Ozen, J. Bonhoeffer, A. Woerner, 2017, Vaccine.

Single organ cutaneous vasculitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.

G. Girolomoni, P. Häusermann, J. Bonhoeffer, 2016, Vaccine.

Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.

M. Gold, J. Bonhoeffer, N. Halsey, 2004, Vaccine.

The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level

A. Dodoo, J. Bonhoeffer, P. Zuber, 2014, Bulletin of the World Health Organization.

Immunisation of premature infants

C. Siegrist, J. Bonhoeffer, P. Heath, 2006, Archives of Disease in Childhood.

Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women.

S. Kochhar, S. Hirschfeld, J. Bauwens, 2016, Vaccine.

Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization.

H. Larson, S. Olsson, S. Black, 2013, Vaccine.

Key terms for the assessment of the safety of vaccines in pregnancy: Results of a global consultative process to initiate harmonization of adverse event definitions

J. Bauwens, M. Katz, J. Ortiz, 2015, Vaccine.

Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.

M. Gold, S. Halperin, U. Heininger, 2004, Vaccine.

Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines.

Robert T. Chen, M. Sturkenboom, K. Laserson, 2013, Vaccine.

Prevalence of Nosocomial Infections in Swiss Children's Hospitals

H. Sax, A. Gervaix, D. Nadal, 2004, Infection Control & Hospital Epidemiology.

Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies.

Robert T. Chen, D. Nalin, M. Gold, 2009, Vaccine.

The Brighton Collaboration: enhancing comparability of vaccine safety data

Robert T. Chen, U. Heininger, J. Bonhoeffer, 2003, Pharmacoepidemiology and Drug Safety.

Current status and future directions of post-marketing vaccine safety monitoring with focus on USA and Europe.

M. Sturkenboom, S. Black, J. Bonhoeffer, 2012, Biologicals : journal of the International Association of Biological Standardization.

Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project

K. Verhamme, M. Sturkenboom, I. Wong, 2015, PloS one.

Template protocol for clinical trials investigating vaccines--focus on safety elements.

Robert T. Chen, S. Kochhar, D. Nalin, 2013, Vaccine.

Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems.

Robert T. Chen, D. Nalin, M. Gold, 2009, Vaccine.

A systematic review of safety data reporting in clinical trials of vaccines against malaria, tuberculosis, and human immunodeficiency virus.

T. Richie, U. Heininger, J. Bonhoeffer, 2013, Vaccine.

Reference set for performance testing of pediatric vaccine safety signal detection methods and systems.

M. Sturkenboom, J. Bonhoeffer, D. Weibel, 2016, Vaccine.

Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines â€“ Multi-country assessment

S. Overeem, J. Kwong, J. Bonhoeffer, 2018 .

Pandemic influenza vaccine & narcolepsy: simulations on the potential impact of bias

M. Sturkenboom, S. Overeem, S. Black, 2016, Expert review of vaccines.

Guillain-Barré Syndrome and Adjuvanted Pandemic Influenza A (H1N1) 2009 Vaccines: A Multinational Self-Controlled Case Series in Europe

Martijn Schuemie, Henrik Svanström, Jan Bonhoeffer, 2014, PloS one.